FDP
ALNY icon

Financiere des Professionnels’s Alnylam Pharmaceuticals ALNY Stock Holding History

Financiere des Professionnels’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$890K Hold
2,689
– – 0.05% 200
2025
Q4 		$1.07M Buy
2,689
+885
+49% +$392K 0.06% 183
2025
Q3 		$823K Buy
+1,804
New +$735K 0.05% 196

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Financiere des Professionnels's ALNY Position: Q1 2026 in Review

Financiere des Professionnels held its Alnylam Pharmaceuticals (ALNY) position steady in Q1 2026 at 2,689 shares worth $890K. The position accounts for 0.05% of the portfolio, ranked #200.

Financiere des Professionnels first reported a position in ALNY in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.07M in Q4 2025. 786 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

  • Financiere des Professionnels held 2,689 shares of Alnylam Pharmaceuticals worth $890K as of Q1 2026.
  • Financiere des Professionnels left its Alnylam Pharmaceuticals share count unchanged in Q1 2026.
  • Alnylam Pharmaceuticals made up 0.05% of Financiere des Professionnels's portfolio in Q1 2026, its #200 holding.
  • Financiere des Professionnels first reported a position in Alnylam Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Financiere des Professionnels's Alnylam Pharmaceuticals position peaked at $1.07M in Q4 2025.
  • 786 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on Financiere des Professionnels's 13F filing for Q1 2026, filed 6 May 2026.